XPHY:CC News and Press, Xphyto Therapeutics Corp. - Common Shares From 09/20/22

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE:4XT) has filed a patent application covering a significant library of novel psychedelic compounds. According to the announcement, each compound included in the filing is designed to provide specific alterations in their respective bi...

VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / September 20, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to report that it has filed a patent application for a significant library of novel psychedelic compounds. Each compo...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / September 2, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) (" XPhyto " or the " Company ") is pleased to announce that further to its new...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / August 31, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTC:XPHYF)(FSE:4XT) (" XPhyto " or the " Company ") is pleased to announce that further to its news re...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / August 2, 2022 / XPhyto Therapeutics Corp. (" XPhyto " or the " Company ") (CSE:XPHY) is pleased to announce that the Company has closed the first tranche of its previou...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / July 22, 2022 / XPhyto Therapeutics Corp. ("XPhyto" or the "Company") (CSE:XPHY) is pleased to announce a non-brokered private placement for gross proceeds of a maximu...

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE:4XT) is taking a close look at a significant potential market for its oral dissolvable ("ODF") biosensor screening tests for oral inflammation. According to the company, some buprenorphine medicines prescribed to treat opioid use dis...

VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / July 15, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY),(OTCQB:XPHYF), (FSE:4XT) ("XPhyto" or the "Company") is pleased to report a significant potential market opportunity for its oral dissolvable ("ODF") biosensor screening tests for ora...

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) today congratulated Prof. Dr. Raimar Loebenberg as the 2022 recipient of the CSPS Award of Leadership in Canadian Pharmaceutical Sciences. Dr. Loebenberg, a director and founder of XPhyto, is a professor in the Faculty of Pharmacy a...

VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / June 27, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) ("XPhyto" or the "Company") is pleased to congratulate Prof. Dr. Raimar Loebenberg as the 2022 recipient of the CSPS Award of Leadership in Canadian Pharmaceutic...